News for BioSyent Inc. (RX.V)

**media[610508]**

**media[594963]**

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therape

**media[586399]**

**media[570155]**

BioSyent Inc. (OTCPK:BIOYF) Q4 2024 Results Conference Call March 13, 2025 5:30 PM ETCompany ParticipantsRene Goehrum - President and CEORene GoehrumWelcome...

MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (”œBioSyent”, TSX Venture: RX) released today its financial results for the fourth q

MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q…

**media[559726]**

MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directo…

**media[507446]**

MISSISSAUGA, Ontario, Dec. 16, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exch…

TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) — This press release is being disseminated as required by National Instrument 62-103 –

**media[471506]**

MISSISSAUGA, Ontario, Nov. 13, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the …

MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) …

MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board...

TORONTO, July 24, 2024 (GLOBE NEWSWIRE) — This press release is being disseminated as required by National Instrument 62-103 –

BioSyent Releases Financial Results for Q1 2024